Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)

Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT).

Keep Reading →